| 摘要 |
PROBLEM TO BE SOLVED: To obtain a new therapeutic agent for allergic ophthalmopathy effective in treating allergic conjunctivitis, spring catarrh, vernal conjunctivitis, etc. SOLUTION: This therapeutic agent for the allergic ophthalmopathy comprises a 6-phenyltetrahydro-1,3-oxazin-2-one derivative represented by general formula (I) [wherein, R1 denotes a 1-8C alkyl group or the like which may have a substituent group; R2 denotes a 1-4C alkyl group; R3 denotes hydrogen atom, a 1-5C alkyl group or the like which may have a substituent group; R4 denotes hydrogen atom, a 1-6C alkyl group or the like which may have a substituent group; and R5 and R6 denote each independently hydrogen atom, a 1-5C alkyl group or the like which may have a substituent group]. |
